Natural history of metabolic dysfunction-associated steatotic liver disease
V Lekakis, GV Papatheodoridis - European Journal of Internal Medicine, 2024 - Elsevier
Metabolic dysfunction-associated steatotic liver disease (MASLD), which has been the term
for non-alcoholic fatty liver disease (NAFLD) since June 2023, represents the most common …
for non-alcoholic fatty liver disease (NAFLD) since June 2023, represents the most common …
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
H Hagström, Y Shang, H Hegmar… - … Lancet Gastroenterology & …, 2024 - thelancet.com
The natural history of metabolic dysfunction-associated steatotic liver disease (MASLD),
previously referred to as non-alcoholic fatty liver disease (NAFLD), is complex and long. A …
previously referred to as non-alcoholic fatty liver disease (NAFLD), is complex and long. A …
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Inflammation is the key driver of liver fibrosis progression in non-alcoholic fatty liver disease
(NAFLD). Unfortunately, it is often challenging to assess inflammation in NAFLD due to its …
(NAFLD). Unfortunately, it is often challenging to assess inflammation in NAFLD due to its …
Endpoints in NASH clinical trials: are we blind in one eye?
This narrative review aims to illustrate the notion that nonalcoholic steatohepatitis (NASH),
recently renamed metabolic dysfunction-associated steatohepatitis (MASH), is a systemic …
recently renamed metabolic dysfunction-associated steatohepatitis (MASH), is a systemic …
[HTML][HTML] A novel experimental mouse model of diabetic nonalcoholic steatohepatitis: A critical role for acid-sensitive Ion Channel 1a
X Hu, H Lin, S Qian, Z Xu, Z Li, S Qian, F Yang… - Biomedicine & …, 2024 - Elsevier
Background A two-way relationship exists between type 2 diabetes (T2DM) and human
nonalcoholic steatohepatitis (NASH). Several diabetic NASH models have the …
nonalcoholic steatohepatitis (NASH). Several diabetic NASH models have the …
Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in metabolic dysfunction-associated steatohepatitis
Alteration in lipid metabolism plays a pivotal role in developing metabolic dysfunction-
associated steatohepatitis (MASH). However, our understanding of alteration in lipid …
associated steatohepatitis (MASH). However, our understanding of alteration in lipid …
Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD
Objectives Currently, non-invasive scoring systems to stage the severity of non-alcoholic
fatty liver disease (NAFLD) do not consider markers of glucose control (glycated …
fatty liver disease (NAFLD) do not consider markers of glucose control (glycated …
Metabolic-associated fatty liver disease and the role of hormones in its aetiopathogenesis
S Suwała, R Junik - Endokrynologia Polska, 2024 - journals.viamedica.pl
Metaboli ca ssociated fatty liver disease (MAFLD) is a newly coined term that links the
presence of liver steatosis (characterised by the accumulation of lipids in at least 5% of liver …
presence of liver steatosis (characterised by the accumulation of lipids in at least 5% of liver …
FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning
Y Ding, Z Wang, H Niu, Q Deng, Y Wang, S Xia - Medicine, 2023 - journals.lww.com
To assess the relationship between clinical biochemical characteristics and steatosis or
fibrosis by Fibroscan in non-alcoholic fatty liver disease (NAFLD) patients in order to seek …
fibrosis by Fibroscan in non-alcoholic fatty liver disease (NAFLD) patients in order to seek …
Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050
Importance Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most
common cause of chronic liver disease and is projected to become the leading indication for …
common cause of chronic liver disease and is projected to become the leading indication for …